Bonalive Biomaterials Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$165K
- Investors
-
1
Bonalive Biomaterials General Information
Description
Manufacturer of implantable medical devices intended to help orthopedic and cranio-maxillofacial surgeons with a fully synthetic bioactive bone regeneration based in Turku, Finland. The company manufactures and sells implantable biomaterials, antibiotic-free products based on bioactive glass S53P4 for bone regeneration used in the surgical treatment of bone infections, diabetic foot osteomyelitis, spinal fusions, benign bone tumor surgery and mastoid surgery, it also provides medical devices and medical information services, thereby helping the patients and surgeons well-proven and safe bone regenerative products with more cost-effective and sustainable procedures and techniques.
Contact Information
Website
www.bonalive.comCorporate Office
- Biolinja 12
- 20750 Turku
- Finland
Corporate Office
- Biolinja 12
- 20750 Turku
- Finland
Bonalive Biomaterials Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Grant | 30-Jun-2015 | $165K | Completed | Generating Revenue |
Bonalive Biomaterials Patents
Bonalive Biomaterials Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017339120-A1 | A bone implant | Inactive | 05-Oct-2016 | ||
| AU-2023200543-A1 | A bone implant | Active | 05-Oct-2016 | ||
| AU-2023200543-B2 | A bone implant | Active | 05-Oct-2016 | ||
| EP-3522944-A1 | A bone implant | Active | 05-Oct-2016 | ||
| EP-3522944-A4 | A bone implant | Active | 05-Oct-2016 | A61L27/10 |
Bonalive Biomaterials Signals
Bonalive Biomaterials Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Union | Government |
Bonalive Biomaterials Investments (1)
Bonalive Biomaterials’s most recent deal was a Joint Venture with TriMed Bonalive. The deal was made on 01-Sep-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| TriMed Bonalive | 01-Sep-2017 | Joint Venture | Medical Supplies |
Bonalive Biomaterials FAQs
-
When was Bonalive Biomaterials founded?
Bonalive Biomaterials was founded in 2009.
-
Where is Bonalive Biomaterials headquartered?
Bonalive Biomaterials is headquartered in Turku, Finland.
-
What is the size of Bonalive Biomaterials?
Bonalive Biomaterials has 40 total employees.
-
What industry is Bonalive Biomaterials in?
Bonalive Biomaterials’s primary industry is Therapeutic Devices.
-
Is Bonalive Biomaterials a private or public company?
Bonalive Biomaterials is a Private company.
-
What is Bonalive Biomaterials’s current revenue?
The current revenue for Bonalive Biomaterials is .
-
Who are Bonalive Biomaterials’s investors?
European Union has invested in Bonalive Biomaterials.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process